1. Home
  2. IMRN vs SGLY Comparison

IMRN vs SGLY Comparison

Compare IMRN & SGLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • SGLY
  • Stock Information
  • Founded
  • IMRN 1994
  • SGLY 2001
  • Country
  • IMRN Australia
  • SGLY United States
  • Employees
  • IMRN N/A
  • SGLY N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • SGLY
  • Sector
  • IMRN Health Care
  • SGLY
  • Exchange
  • IMRN Nasdaq
  • SGLY Nasdaq
  • Market Cap
  • IMRN 15.0M
  • SGLY 5.8M
  • IPO Year
  • IMRN N/A
  • SGLY 2008
  • Fundamental
  • Price
  • IMRN $2.25
  • SGLY $1.65
  • Analyst Decision
  • IMRN Strong Buy
  • SGLY
  • Analyst Count
  • IMRN 1
  • SGLY 0
  • Target Price
  • IMRN $5.00
  • SGLY N/A
  • AVG Volume (30 Days)
  • IMRN 7.2K
  • SGLY 153.8K
  • Earning Date
  • IMRN 10-22-2024
  • SGLY 11-11-2024
  • Dividend Yield
  • IMRN N/A
  • SGLY N/A
  • EPS Growth
  • IMRN N/A
  • SGLY N/A
  • EPS
  • IMRN N/A
  • SGLY N/A
  • Revenue
  • IMRN $3,271,194.00
  • SGLY $3,370,424.00
  • Revenue This Year
  • IMRN N/A
  • SGLY N/A
  • Revenue Next Year
  • IMRN N/A
  • SGLY N/A
  • P/E Ratio
  • IMRN N/A
  • SGLY N/A
  • Revenue Growth
  • IMRN 171.67
  • SGLY N/A
  • 52 Week Low
  • IMRN $1.48
  • SGLY $1.27
  • 52 Week High
  • IMRN $5.96
  • SGLY $7.65
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 32.37
  • SGLY 41.57
  • Support Level
  • IMRN $2.66
  • SGLY $1.55
  • Resistance Level
  • IMRN $2.73
  • SGLY $1.79
  • Average True Range (ATR)
  • IMRN 0.19
  • SGLY 0.19
  • MACD
  • IMRN -0.06
  • SGLY 0.10
  • Stochastic Oscillator
  • IMRN 24.04
  • SGLY 61.29

About IMRN Immuron Limited

Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

About SGLY Singularity Future Technology Ltd.

Singularity Future Technology Ltd is an investment holding company. The company's operating segment includes Freight Logistics Services and Sale of Crypto-mining Machines. It generates maximum revenue from the Freight Logistics Services segment. Geographically, it derives a majority of its revenue from China.

Share on Social Networks: